The Everee Women™ range has been developed based on pre-clinical and clinical studies demonstrated through peer reviewed published data on the components of each product and their mechanism of action.

Everee Women™ products contain a high proportion of cystine rich peptides. In vitro studies by the University of Miami Department of Dermatology published in Experimental Dermatology (11) demonstrate skin cells have increased expression of collagen IV in the presence of cystine rich peptides. Further ex-vivo studies on hair follicles published in Cosmetics and Toiletries (9) demonstrate collagen IV expression around hair follicles to improve hair follicle anchoring.

High tyrosine proteins, such as those in the Everee Women™ range, have been shown to increase dopamine levels in the brain of animals, in a study published in the Journal of Nutrition by the University of Pittsburgh School of Medicine (1). A study on 11 Parkinsons patients supplemented with the blackcurrant extract cGP-Pro, published in Nutrients by the University of Auckland demonstrated elevated levels of cyclic glycine-proline in brain fluid, this has been shown to modulate IGF-1 (20). This has clinical significance in ageing of the brain and in age-related neurological conditions, such as dementia, and improving memory and stroke recovery. Menopausal studies on the importance of glutamic acid dependant GABA have been published by the Memory and Aging Laboratory, Department of Psychology, Arizona State University, and shown the connection to memory improvement (16).

A randomised controlled trial in 35 diabetic adults published by Massey University showed improvement in both glucose clearance and insulin sensitivity for cystine rich peptides, such as those in Everee Women™ compared to dairy protein controls (19). Cyclic glycine-proline (cGP) contained in Everee#4 has been shown to affect IGF-1 metabolism which impacts circulation in published studies by the University of Auckland (20).